Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-222007
Filing Date
2017-07-05
Accepted
2017-07-05 16:11:55
Documents
3
Period of Report
2017-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d418589d6k.htm 6-K 9987
2 EX-99.1 d418589dex991.htm EX-99.1 17533
3 GRAPHIC g418589g0705204141035.jpg GRAPHIC 2478
  Complete submission text file 0001193125-17-222007.txt   32120
Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 17948119
SIC: 2834 Pharmaceutical Preparations